Jubilant Pharmova Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LEVETIRACETAM USP, with a corresponding US DMF Number 24200.
Remarkably, this DMF maintains an Active status since its submission on October 28, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 31, 2013, and payment made on April 01, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II